BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23772751)

  • 1. Risk assessment of echocardiographic left ventricular hypertrophy with electrocardiography, body mass index and blood pressure.
    Varis JP; Puukka PJ; Karanko HM; Jula AM
    Blood Press; 2014 Feb; 23(1):39-46. PubMed ID: 23772751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
    Xie L; Wang Z
    Hellenic J Cardiol; 2010; 51(5):391-401. PubMed ID: 20876051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study.
    Zhang W; Zhou Y; Bai B; Yu S; Xiong J; Chi C; Teliewubai J; Li J; Blacher J; Zhang Y; Xu Y
    Clin Interv Aging; 2019; 14():549-556. PubMed ID: 30880935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
    Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.
    Ishikawa J; Yamanaka Y; Toba A; Watanabe S; Harada K
    Int Heart J; 2017 Dec; 58(6):933-938. PubMed ID: 29162779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
    Okin PM; Gerdts E; Wachtell K; Oikarinen L; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2010 Jul; 28(7):1534-40. PubMed ID: 20589977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease.
    Cordeiro AC; Lindholm B; Sousa MG; Picotti JC; Nunes GJ; Santana MR; Grimaldi W; Amparo FC; Amodeo C; Carrero JJ
    J Hypertens; 2014 Feb; 32(2):439-45. PubMed ID: 24317549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity.
    Norman JE; Levy D
    J Electrocardiol; 1996; 29 Suppl():241-7. PubMed ID: 9238407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants and improvement of electrocardiographic diagnosis of left ventricular hypertrophy in a black African population.
    Jingi AM; Noubiap JJ; Kamdem P; Kingue S
    PLoS One; 2014; 9(5):e96783. PubMed ID: 24810594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
    Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.